vbp15 to treat duchenne muscular dystrophy - clinical trial update
Published 9 years ago • 516 plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
4:40
vbp15 - a new & improved glucocorticoid for duchenne?
-
2:46
hanugen therapeutics on clinical trials for treatment of rare disease duchenne muscular dystrophy
-
4:07
why vbp15 may be well suited for treating duchenne
-
4:47
duchenne policy forum to optimize clinical trials
-
3:20
duchenne boys - are they too diverse to get a clinical trial effective
-
1:03:36
emerging therapies for duchenne muscular dystrophy
-
1:56
pfizer's phase 2 duchenne clinical trial
-
2:29
imaging biomarkers in duchenne muscular dystrophy
-
![trials in duchenne - santhera [ppmd's 2016 connect conference]](https://i.ytimg.com/vi/jTCXb-cCS8I/mqdefault.jpg)
23:25
trials in duchenne - santhera [ppmd's 2016 connect conference]
-
4:40
developing customized, novel rare disease therapies: meet rich | the disruptors
-
17:21
in the pipeline: gene therapy - pfizer inc.
-
3:08:06
ppmd 2018 conference - understanding the diagnosis of duchenne
-
![[webinar] vamorolone clinical trials in duchenne - january 2019](https://i.ytimg.com/vi/uwD9MM1tSnE/mqdefault.jpg)
59:41
[webinar] vamorolone clinical trials in duchenne - january 2019
-
4:55
duchenne md clinical trial
-
3:14
other treatment updates for dmd
-
19:15
lilly east, phd & erica koenig, phd | how rare disease leaders kept research momentum strong
-
33:03
the stride registry for duchenne muscular dystrophy
-
11:45
duchenne muscular dystrophy and its treatment options
-
47:30
duchenne landscape: where we've come from & how we're moving forward -- ppmd 2022 annual conference